Queen’s University Belfast team makes a massive colon cancer breakthrough

New findings emerging from the research team at Queen’s University Belfast have identified a cellular process which can be exploited in order to kill BRAF mutant colon cancer cells, a particularly aggressive subgroup of colon cancers. These cancers are not only extremely aggressive but they do not respond well to conventional cancer treatments.

The QUB team behind the discovery describe it as a “ground-breaking therapeutic process that can target and kill bowel cancer cells”. The treatment will be a key tool in tackling the most aggressive form of the illness which conventional treatments have little or no impact on. The revolutionary technique may improve survival rates for colon cancer patients globally.

Professor Sandra Van Schaeybroeck, remarked: “This research is good news for bowel cancer patients as further clinical trials investigating the effect of such agents could improve the survival outcome of patients in Northern Ireland and beyond.”

Congratulations to all researchers involved!

Here is some digital press coverage of this story:

https://www.thetimes.co.uk/article/belfast-team-discover-way-to-target-bowel-cancer-cells-thxqltfqw

https://www.irishtimes.com/news/health/bowel-cancer-breakthrough-discovered-at-queen-s-university-belfast-1.3619261

https://www.rte.ie/news/2018/0906/991937-qub_bowel_cancer/

https://www.bbc.co.uk/news/uk-northern-ireland-45431053

http://www.dailymail.co.uk/wires/pa/article-6136787/New-bowel-cancer-treatment-improve-survival-rates.html?ns_mchannel=rss&ito=1490&ns_campaign=1490

http://www.oxfordtimes.co.uk/news/national/16691154.new-bowel-cancer-treatment-may-improve-survival-rates/

Belfast Telegraph

The Daily Mirror

The Newsletter

MErCuRIC celebrates International Clinical Trials Day 2018

In celebration of International Clinical Trials Day on 18 May 2018, an exhibition showcased cancer clinical studies in the Northern Ireland Cancer Centre. MErCuRIC and all open clinical studies where there was local leadership were promoted.

Patient representatives Margaret Grayson and Dr Edward Goodall were part of the team from the Northern Ireland Cancer Research Consumer Forum (NICRCF), Northern Ireland Cancer Trials Network  (NICTN) and several cancer charities who were on hand to share information and their own experience. There was a great support from staff, patients and visitors.

                 

New Website Launched

Thank you very much for visiting our new website for the MErCuRIC project.

We’ll be updating the site over the next few weeks.